Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001209191-19-019767

Chief Technical Officer acquired 37,050 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MOORE ALISON Chief Technical Officer 2019-03-13 Grant or award +37,050 37,050 D
Derivatives
MOORE ALISON Chief Technical Officer 2019-03-13 Grant or award · Employee Stock Option (Right to Buy) +83,500 83,500 D
Loading xslF345X03/doc4.xml…